Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering

As genome engineering advances cell-based therapies, a versatile approach to introducing both CRISPR-Cas9 ribonucleoproteins (RNPs) and therapeutic transgenes into specific cells would be transformative. Autologous T cells expressing a chimeric antigen receptor (CAR) manufactured by viral transducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jennifer R., Tsuchida, Connor A., Nguyen, David N., Shy, Brian R., McGarrigle, E. Riley, Sandoval Espinoza, Cindy R., Carr, Daniel, Blaeschke, Franziska, Marson, Alexander, Doudna, Jennifer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236216/
https://www.ncbi.nlm.nih.gov/pubmed/34077734
http://dx.doi.org/10.1016/j.celrep.2021.109207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236216/
https://www.ncbi.nlm.nih.gov/pubmed/34077734
http://dx.doi.org/10.1016/j.celrep.2021.109207

Ejemplares similares